Matthew Caufield's Stock Ratings

HC Wainwright & Co. Analyst

Matthew Caufield is an analyst at HC Wainwright & Co.. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025

Overall Average Return

-29.5%

Smart Score

37.1%

Overall Average Return Percentile

7th

Number of Ratings

127
Buy NowGet Alert
03/14/2025LYRABuy Now
Lyra Therapeutics
$0.161112.86%
Matthew Caufield37%
$2 → $2ReiteratesNeutral → NeutralGet Alert
03/12/2025ZBIOBuy Now
Zenas BioPharma
$7.90279.75%
Matthew Caufield37%
$30 → $30ReiteratesBuy → BuyGet Alert
03/10/2025MLYSBuy Now
Mineralys Therapeutics
$15.4394.43%
Matthew Caufield37%
$30 → $30ReiteratesBuy → BuyGet Alert
03/10/2025UBXBuy Now
Unity Biotechnology
$1.81341.87%
Matthew Caufield37%
$8 → $8ReiteratesBuy → BuyGet Alert
03/07/2025PHATBuy Now
Phathom Pharmaceuticals
$5.78384.5%
Matthew Caufield37%
$28 → $28ReiteratesBuy → BuyGet Alert
03/03/2025ALDXBuy Now
Aldeyra Therapeutics
$6.5851.95%
Matthew Caufield37%
$10 → $10ReiteratesBuy → BuyGet Alert
03/03/2025FDMTBuy Now
4D Molecular Therapeutics
$3.96809.09%
Matthew Caufield37%
$36 → $36ReiteratesBuy → BuyGet Alert
02/28/2025OPTBuy Now
Opthea
$3.31262.54%
Matthew Caufield37%
$12 → $12ReiteratesBuy → BuyGet Alert
02/21/2025IMUXBuy Now
Immunic
$1.14777.19%
Matthew Caufield37%
$10 → $10ReiteratesBuy → BuyGet Alert
02/19/2025IRDBuy Now
Opus Genetics
$1.15596.62%
Matthew Caufield37%
$8 → $8ReiteratesBuy → BuyGet Alert
02/13/2025MLYSBuy Now
Mineralys Therapeutics
$15.4394.43%
Matthew Caufield37%
$30 → $30ReiteratesBuy → BuyGet Alert
02/13/2025FBLGBuy Now
FibroBiologics
$1.021076.47%
Matthew Caufield37%
$12 → $12ReiteratesBuy → BuyGet Alert
02/10/2025FDMTBuy Now
4D Molecular Therapeutics
$3.96809.09%
Matthew Caufield37%
$36 → $36ReiteratesBuy → BuyGet Alert
02/06/2025EYENBuy Now
Eyenovia
$1.5529.03%
Matthew Caufield37%
$2 → $2ReiteratesNeutral → NeutralGet Alert
01/30/2025SRZNBuy Now
Surrozen
$11.00190.91%
Matthew Caufield37%
→ $32Initiates → BuyGet Alert
01/29/2025OPTBuy Now
Opthea
$3.31262.54%
Matthew Caufield37%
$12 → $12ReiteratesBuy → BuyGet Alert
01/13/2025FDMTBuy Now
4D Molecular Therapeutics
$3.96809.09%
Matthew Caufield37%
$36 → $36ReiteratesBuy → BuyGet Alert
01/03/2025OPTNBuy Now
OptiNose
$5.85207.69%
Matthew Caufield37%
$5 → $18MaintainsBuyGet Alert
12/16/2024ZBIOBuy Now
Zenas BioPharma
$7.90279.75%
Matthew Caufield37%
→ $30Initiates → BuyGet Alert
12/12/2024PHATBuy Now
Phathom Pharmaceuticals
$5.78384.5%
Matthew Caufield37%
$28 → $28ReiteratesBuy → BuyGet Alert
12/12/2024IRDBuy Now
Opus Genetics
$1.15596.62%
Matthew Caufield37%
$8 → $8ReiteratesBuy → BuyGet Alert
11/25/2024IMUXBuy Now
Immunic
$1.14777.19%
Matthew Caufield37%
→ $10Initiates → BuyGet Alert
11/19/2024ADVMBuy Now
Adverum Biotechnologies
$5.07491.72%
Matthew Caufield37%
$30 → $30ReiteratesBuy → BuyGet Alert
11/18/2024EYENBuy Now
Eyenovia
$1.5529.03%
Matthew Caufield37%
$960 → $160DowngradeBuy → NeutralGet Alert
11/15/2024KODBuy Now
Kodiak Sciences
$3.24-7.41%
Matthew Caufield37%
$3 → $3ReiteratesNeutral → NeutralGet Alert
11/15/2024DMACBuy Now
DiaMedica Therapeutics
$5.7022.81%
Matthew Caufield37%
$7 → $7ReiteratesBuy → BuyGet Alert
11/14/2024FDMTBuy Now
4D Molecular Therapeutics
$3.96809.09%
Matthew Caufield37%
$36 → $36ReiteratesBuy → BuyGet Alert
11/13/2024FBLGBuy Now
FibroBiologics
$1.021076.47%
Matthew Caufield37%
$12 → $12ReiteratesBuy → BuyGet Alert
11/13/2024EYENBuy Now
Eyenovia
$1.55674.19%
Matthew Caufield37%
$960 → $960ReiteratesBuy → BuyGet Alert
11/13/2024OPTNBuy Now
OptiNose
$5.85-14.53%
Matthew Caufield37%
$75 → $75ReiteratesBuy → BuyGet Alert
11/12/2024MLYSBuy Now
Mineralys Therapeutics
$15.4394.43%
Matthew Caufield37%
$30 → $30ReiteratesBuy → BuyGet Alert
11/07/2024LENZBuy Now
LENZ Therapeutics
$24.0058.33%
Matthew Caufield37%
$38 → $38ReiteratesBuy → BuyGet Alert
10/31/2024MLYSBuy Now
Mineralys Therapeutics
$15.4394.43%
Matthew Caufield37%
$30 → $30ReiteratesBuy → BuyGet Alert
10/30/2024FBLGBuy Now
FibroBiologics
$1.021076.47%
Matthew Caufield37%
→ $12Initiates → BuyGet Alert
10/10/2024DMACBuy Now
DiaMedica Therapeutics
$5.7022.81%
Matthew Caufield37%
$7 → $7ReiteratesBuy → BuyGet Alert
10/07/2024DMACBuy Now
DiaMedica Therapeutics
$5.7022.81%
Matthew Caufield37%
→ $7Initiates → BuyGet Alert
09/24/2024KODBuy Now
Kodiak Sciences
$3.24-7.41%
Matthew Caufield37%
$3 → $3ReiteratesNeutral → NeutralGet Alert
09/19/2024FDMTBuy Now
4D Molecular Therapeutics
$3.96809.09%
Matthew Caufield37%
$36 → $36ReiteratesBuy → BuyGet Alert
09/05/2024KODBuy Now
Kodiak Sciences
$3.24-7.41%
Matthew Caufield37%
→ $3Initiates → NeutralGet Alert
09/03/2024OPTBuy Now
Opthea
$3.31262.54%
Matthew Caufield37%
$14 → $12MaintainsBuyGet Alert
08/15/2024LYRABuy Now
Lyra Therapeutics
$0.161112.86%
Matthew Caufield37%
$2 → $2ReiteratesNeutral → NeutralGet Alert
08/15/2024LENZBuy Now
LENZ Therapeutics
$24.0058.33%
Matthew Caufield37%
$38 → $38ReiteratesBuy → BuyGet Alert
08/15/2024OCUPBuy Now
Ocuphire Pharma
Matthew Caufield37%
$20 → $18MaintainsBuyGet Alert
08/15/2024MLYSBuy Now
Mineralys Therapeutics
$15.4394.43%
Matthew Caufield37%
$30 → $30ReiteratesBuy → BuyGet Alert
08/13/2024ADVMBuy Now
Adverum Biotechnologies
$5.07491.72%
Matthew Caufield37%
$30 → $30ReiteratesBuy → BuyGet Alert
08/13/2024EYENBuy Now
Eyenovia
$1.55674.19%
Matthew Caufield37%
$960 → $960ReiteratesBuy → BuyGet Alert
08/12/2024HLVXBuy Now
HilleVax
$1.7216.28%
Matthew Caufield37%
$2 → $2ReiteratesNeutral → NeutralGet Alert
08/12/2024LENZBuy Now
LENZ Therapeutics
$24.0058.33%
Matthew Caufield37%
→ $38Initiates → BuyGet Alert
08/12/2024PHATBuy Now
Phathom Pharmaceuticals
$5.78384.5%
Matthew Caufield37%
$28 → $28ReiteratesBuy → BuyGet Alert
08/09/2024FDMTBuy Now
4D Molecular Therapeutics
$3.96809.09%
Matthew Caufield37%
$36 → $36ReiteratesBuy → BuyGet Alert
08/09/2024ALDXBuy Now
Aldeyra Therapeutics
$6.5851.95%
Matthew Caufield37%
$10 → $10ReiteratesBuy → BuyGet Alert
08/02/2024ALDXBuy Now
Aldeyra Therapeutics
$6.5851.95%
Matthew Caufield37%
$10 → $10ReiteratesBuy → BuyGet Alert
07/24/2024EYENBuy Now
Eyenovia
$1.55674.19%
Matthew Caufield37%
$960 → $960ReiteratesBuy → BuyGet Alert
07/19/2024PHATBuy Now
Phathom Pharmaceuticals
$5.78384.5%
Matthew Caufield37%
$28 → $28ReiteratesBuy → BuyGet Alert
07/10/2024MLYSBuy Now
Mineralys Therapeutics
$15.4394.43%
Matthew Caufield37%
→ $30Initiates → BuyGet Alert
07/09/2024HLVXBuy Now
HilleVax
$1.72
Matthew Caufield37%
DowngradeBuy → NeutralGet Alert
06/07/2024FDMTBuy Now
4D Molecular Therapeutics
$3.96809.09%
Matthew Caufield37%
$36 → $36ReiteratesBuy → BuyGet Alert
05/16/2024EYENBuy Now
Eyenovia
$1.55674.19%
Matthew Caufield37%
$960 → $960ReiteratesBuy → BuyGet Alert
05/15/2024OPTNBuy Now
OptiNose
$5.85-14.53%
Matthew Caufield37%
$75 → $75ReiteratesBuy → BuyGet Alert
05/13/2024OCUPBuy Now
Ocuphire Pharma
Matthew Caufield37%
$20 → $20ReiteratesBuy → BuyGet Alert
05/13/2024FDMTBuy Now
4D Molecular Therapeutics
$3.96809.09%
Matthew Caufield37%
$36 → $36ReiteratesBuy → BuyGet Alert
05/10/2024PHATBuy Now
Phathom Pharmaceuticals
$5.78384.5%
Matthew Caufield37%
$28 → $28ReiteratesBuy → BuyGet Alert
05/10/2024HLVXBuy Now
HilleVax
$1.721527.91%
Matthew Caufield37%
$28 → $28ReiteratesBuy → BuyGet Alert
05/10/2024ADVMBuy Now
Adverum Biotechnologies
$5.07491.72%
Matthew Caufield37%
$30 → $30ReiteratesBuy → BuyGet Alert
05/07/2024LYRABuy Now
Lyra Therapeutics
$0.161112.86%
Matthew Caufield37%
→ $2DowngradeBuy → NeutralGet Alert
05/06/2024ALDXBuy Now
Aldeyra Therapeutics
$6.5851.95%
Matthew Caufield37%
$10 → $10ReiteratesBuy → BuyGet Alert
05/01/2024LYRABuy Now
Lyra Therapeutics
$0.167177.14%
Matthew Caufield37%
$12 → $12ReiteratesBuy → BuyGet Alert
04/30/2024ADVMBuy Now
Adverum Biotechnologies
$5.07491.72%
Matthew Caufield37%
→ $30Initiates → BuyGet Alert
04/29/2024OPTNBuy Now
OptiNose
$5.85-14.53%
Matthew Caufield37%
$75 → $75ReiteratesBuy → BuyGet Alert
04/02/2024ALDXBuy Now
Aldeyra Therapeutics
$6.5851.95%
Matthew Caufield37%
→ $10ReinstatesBuy → BuyGet Alert
03/22/2024LYRABuy Now
Lyra Therapeutics
$0.167177.14%
Matthew Caufield37%
$12 → $12ReiteratesBuy → BuyGet Alert
03/21/2024HLVXBuy Now
HilleVax
$1.721527.91%
Matthew Caufield37%
$28 → $28ReiteratesBuy → BuyGet Alert
03/19/2024EYENBuy Now
Eyenovia
$1.55674.19%
Matthew Caufield37%
$960 → $960ReiteratesBuy → BuyGet Alert
03/18/2024OPTNBuy Now
OptiNose
$5.85-14.53%
Matthew Caufield37%
$75 → $75ReiteratesBuy → BuyGet Alert
03/11/2024OCUPBuy Now
Ocuphire Pharma
Matthew Caufield37%
$20 → $20ReiteratesBuy → BuyGet Alert
03/11/2024OPTNBuy Now
OptiNose
$5.85-14.53%
Matthew Caufield37%
→ $75Initiates → BuyGet Alert
03/08/2024PHATBuy Now
Phathom Pharmaceuticals
$5.78384.5%
Matthew Caufield37%
$28 → $28ReiteratesBuy → BuyGet Alert
03/06/2024EYENBuy Now
Eyenovia
$1.55674.19%
Matthew Caufield37%
$960 → $960ReiteratesBuy → BuyGet Alert
03/01/2024FDMTBuy Now
4D Molecular Therapeutics
$3.96809.09%
Matthew Caufield37%
$36 → $36ReiteratesBuy → BuyGet Alert
12/13/2023HLVXBuy Now
HilleVax
$1.721527.91%
Matthew Caufield37%
→ $28Initiates → BuyGet Alert
11/14/2023OCUPBuy Now
Ocuphire Pharma
Matthew Caufield37%
→ $20ReiteratesBuy → BuyGet Alert
11/14/2023UBXBuy Now
Unity Biotechnology
$1.81452.33%
Matthew Caufield37%
→ $10ReiteratesBuy → BuyGet Alert
11/14/2023EYENBuy Now
Eyenovia
$1.55674.19%
Matthew Caufield37%
→ $960ReiteratesBuy → BuyGet Alert
10/02/2023LYRABuy Now
Lyra Therapeutics
$0.167177.14%
Matthew Caufield37%
→ $12ReiteratesBuy → BuyGet Alert
08/31/2023LYRABuy Now
Lyra Therapeutics
$0.167177.14%
Matthew Caufield37%
→ $12Initiates → BuyGet Alert
08/22/2023FNBuy Now
Fabrinet
$222.86-87.44%
Matthew Caufield37%
→ $28ReiteratesBuy → BuyGet Alert
08/18/2023EYENBuy Now
Eyenovia
$1.55674.19%
Matthew Caufield37%
→ $960ReiteratesBuy → BuyGet Alert
08/14/2023OCUPBuy Now
Ocuphire Pharma
Matthew Caufield37%
→ $20ReiteratesBuy → BuyGet Alert
08/11/2023PHATBuy Now
Phathom Pharmaceuticals
$5.78384.5%
Matthew Caufield37%
→ $28ReiteratesBuy → BuyGet Alert
08/11/2023EYENBuy Now
Eyenovia
$1.55674.19%
Matthew Caufield37%
→ $960ReiteratesBuy → BuyGet Alert
08/10/2023FDMTBuy Now
4D Molecular Therapeutics
$3.96809.09%
Matthew Caufield37%
→ $36ReiteratesBuy → BuyGet Alert
08/09/2023PHATBuy Now
Phathom Pharmaceuticals
$5.78384.5%
Matthew Caufield37%
→ $28Initiates → BuyGet Alert
08/09/2023UBXBuy Now
Unity Biotechnology
$1.81452.33%
Matthew Caufield37%
→ $10ReiteratesBuy → BuyGet Alert
08/01/2023OPTBuy Now
Opthea
$3.31322.96%
Matthew Caufield37%
→ $14ReiteratesBuy → BuyGet Alert
07/31/2023FDMTBuy Now
4D Molecular Therapeutics
$3.96809.09%
Matthew Caufield37%
→ $36ReiteratesBuy → BuyGet Alert
06/30/2023ALDXBuy Now
Aldeyra Therapeutics
$6.58127.93%
Matthew Caufield37%
→ $15ReiteratesBuy → BuyGet Alert
06/22/2023ALDXBuy Now
Aldeyra Therapeutics
$6.58127.93%
Matthew Caufield37%
→ $15ReiteratesBuy → BuyGet Alert
06/16/2023ALDXBuy Now
Aldeyra Therapeutics
$6.58127.93%
Matthew Caufield37%
→ $15ReiteratesBuy → BuyGet Alert
06/08/2023FDMTBuy Now
4D Molecular Therapeutics
$3.96809.09%
Matthew Caufield37%
→ $36ReiteratesBuy → BuyGet Alert
05/16/2023OCUPBuy Now
Ocuphire Pharma
Matthew Caufield37%
→ $20ReiteratesBuy → BuyGet Alert
05/12/2023EYENBuy Now
Eyenovia
$1.55674.19%
Matthew Caufield37%
→ $960ReiteratesBuy → BuyGet Alert
05/11/2023FDMTBuy Now
4D Molecular Therapeutics
$3.96809.09%
Matthew Caufield37%
→ $36ReiteratesBuy → BuyGet Alert
05/10/2023UBXBuy Now
Unity Biotechnology
$1.81452.33%
Matthew Caufield37%
→ $10Reiterates → BuyGet Alert
05/05/2023ALDXBuy Now
Aldeyra Therapeutics
$6.58127.93%
Matthew Caufield37%
→ $15Reiterates → BuyGet Alert
05/02/2023ISEEBuy Now
IVERIC bio
Matthew Caufield37%
$35 → $40DowngradeBuy → NeutralGet Alert
04/28/2023FDMTBuy Now
4D Molecular Therapeutics
$3.96809.09%
Matthew Caufield37%
→ $36Reiterates → BuyGet Alert
04/19/2023EYENBuy Now
Eyenovia
$1.55674.19%
Matthew Caufield37%
→ $960Reiterates → BuyGet Alert
04/03/2023EYENBuy Now
Eyenovia
$1.55674.19%
Matthew Caufield37%
→ $960Reiterates → BuyGet Alert
03/31/2023OCUPBuy Now
Ocuphire Pharma
Matthew Caufield37%
→ $20Reiterates → BuyGet Alert
03/28/2023UBXBuy Now
Unity Biotechnology
$1.81452.33%
Matthew Caufield37%
→ $10Reiterates → BuyGet Alert
03/16/2023FDMTBuy Now
4D Molecular Therapeutics
$3.96809.09%
Matthew Caufield37%
→ $36Reiterates → BuyGet Alert
03/10/2023ALDXBuy Now
Aldeyra Therapeutics
$6.58127.93%
Matthew Caufield37%
→ $15Reiterates → BuyGet Alert
03/02/2023ISEEBuy Now
IVERIC bio
Matthew Caufield37%
→ $35Reiterates → BuyGet Alert
03/01/2023ALDXBuy Now
Aldeyra Therapeutics
$6.58127.93%
Matthew Caufield37%
→ $15Reiterates → BuyGet Alert
02/24/2023OPTBuy Now
Opthea
$3.31322.96%
Matthew Caufield37%
→ $14Reiterates → BuyGet Alert
02/23/2023FDMTBuy Now
4D Molecular Therapeutics
$3.96809.09%
Matthew Caufield37%
→ $36Reiterates → BuyGet Alert
02/17/2023OCUPBuy Now
Ocuphire Pharma
Matthew Caufield37%
→ $20Reiterates → BuyGet Alert
02/17/2023ISEEBuy Now
IVERIC bio
Matthew Caufield37%
→ $35Reiterates → BuyGet Alert
02/06/2023FDMTBuy Now
4D Molecular Therapeutics
$3.96809.09%
Matthew Caufield37%
→ $36Reiterates → BuyGet Alert
01/26/2023OCUPBuy Now
Ocuphire Pharma
Matthew Caufield37%
$26 → $20MaintainsBuyGet Alert
12/08/2022OPTBuy Now
Opthea
$3.31322.96%
Matthew Caufield37%
→ $14Initiates → BuyGet Alert
11/18/2022FDMTBuy Now
4D Molecular Therapeutics
$3.96809.09%
Matthew Caufield37%
→ $36Initiates → BuyGet Alert
11/04/2022ISEEBuy Now
IVERIC bio
Matthew Caufield37%
$26 → $35MaintainsBuyGet Alert
10/05/2022EYENBuy Now
Eyenovia
$1.55674.19%
Matthew Caufield37%
→ $960Initiates → BuyGet Alert
07/18/2022OYSTBuy Now
Oyster Point Pharma
Matthew Caufield37%
→ $20Initiates → BuyGet Alert
11/10/2021ISEEBuy Now
IVERIC bio
Matthew Caufield37%
$20 → $26MaintainsBuyGet Alert
08/19/2021ISEEBuy Now
IVERIC bio
Matthew Caufield37%
→ $20Initiates → BuyGet Alert